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The dysbiosis of the human intestinal microbiota is linked to sporadic colorectal carcinoma
(CRC). The present study was designed to investigate the gut microbiota distribution
features in CRC patients. We performed pyrosequencing based analysis of the 16S
rRNA gene V3 region to investigate microbiota of the cancerous tissue and adjacent
non-cancerous normal tissue in proximal and distal CRC samples. The results revealed
that the microbial structures of the CRC patients and healthy individuals differed
significantly. Firmicutes and Fusobacteria were over-represented whereas Proteobacteria
was under-represented in CRC patients. In addition, Lactococcus and Fusobacterium
exhibited a relatively higher abundance while Pseudomonas and Escherichia-Shigella was
reduced in cancerous tissues compared to adjacent non-cancerous tissues. Meanwhile,
the overall microbial structures of proximal and distal colon cancerous tissues were
similar; but certain potential pro-oncogenic pathogens were different. These results
suggested that the mucosa-associated microbiota is dynamically associated with CRC,
which may provide evidences for microbiota-associated diagnostic, prognostic, preventive,
and therapeutic strategies for CRC.
Keywords: colorectal cancer, proximal colon, distal colon, mucosa-associated microbiota, gut dysbiosis
INTRODUCTION
Colorectal cancer is the third most common cancer and the
fourth leading cause of cancer deaths worldwide, accounting
for approximately 1.2 million new cases and 600,000 deaths
per year (Brenner et al., 2014). Based on embryological, mor-
phologic, physiological, and biochemical differences in anatomic
sites, Bufill proposed the existence of distinct categories of
CRC according to the location of the tumor in the proximal
(right) or distal (left) segments relative to the splenic flexure.
Epidemiologic studies showed the difference in terms of inci-
dence of CRC (Bufill, 1990). For example, rectal cancer accounted
for beyond 50% in proportion of all CRC in some south, cen-
tral Asia and South America countries, whereas the incidence
of colon cancer is beyond of rectum cancer in the countries of
Europe, North America (Takada et al., 2002). Many risk factors
are associated with CRC, including inflammatory bowel dis-
ease, smoking, excessive alcohol consumption, high consumption
of red and processed meat, obesity, and diabetes. For exam-
ple, high dietary fat intake has been reported to increase the
risk of proximal cancers while high protein intake increases the
incidence of distal cancers (McMichael and Potter, 1985; West
et al., 1989). Another case-control study of Chinese who reside
in North America show high carbohydrate intake is associated
with increased right colon cancer in women but increased rec-
tal cancer amongst men (Borugian et al., 2002). At present, there
is substantial evidence suggesting that the environmental fac-
tors mentioned above markedly affect the intestinal microbiota
composition (Wu et al., 2011). Moreover, there is unequivocal
evidence linking gut dysbiosis to CRC development (Schwabe
and Jobin, 2013). It is evaluated that the human gastroin-
testinal tract harbors approximately 1000 species of bacteria
estimating 1014 cells, which constitute about 90% of all cells
in the human body (Qin et al., 2010). In addition to influenc-
ing host nutrition via metabolism, the intestinal microbiota can
play both beneficial and detrimental roles by controlling epithe-
lial proliferation and differentiation (Srikanth and McCormick,
2008).
Accumulated studies show that several bacterial species seem
to involve in pathogenesis of CRC (Srikanth and McCormick,
2008; Castellarin et al., 2011; Kostic et al., 2011; Marchesi et al.,
2011). Streptococcus Gallolyticus (Formerly Streptococcus bovis) is
present approximately 20–50% of colon tumors and less than
5% in the normal colon. Wei and his colleagues report that
the abundance of Ruminococcus obeum and Allobaculum-like
bacteria are increased in the feces of 1,2-dimethyl hydrazine
(DMH)-treated rats developing precancerous mucosal lesions
(Wei et al., 2010). In addition, a significant elevation of the
Bacteroides/Prevotella population is reported. Bifidobacterium
longum, Clostridium clostridioforme, and Ruminococcus bromii are
under-represented in RC patients compared to healthy individu-
als (Sobhani et al., 2011). Fusobacterium nucleatum is found over-
represented in tumor micro- environment (Ray, 2011). Recent
studies have provided mechanistic evidence for the involvement
of gut bacteria in the development of CRC. Animal experiment
reveals that mutant mice that are genetically susceptible to CRC
develop significantly fewer tumors under germ-free conditions
than when they have a conventional microbiota (Uronis et al.,
2009). Extracellular genotoxins and DNA damaging superox-
ide radicals produced by Enterococcus faecalis can contribute to
CRC development (Huycke et al., 2002; Wang and Huycke, 2007;
Wang et al., 2008). DNA damage also can be induced by geno-
toxic Escherichia coliwhich harbor the polyketide synthetase (pks)
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island and encode a genotoxin called colibactin (Nougayrède
et al., 2006;Cuevas-Ramos et al., 2010).
However, previous studies have suggested that different bacte-
rial species preferentially inhabit the tumor sites. It is not yet clear
whether the over-representation or under-representation of par-
ticular microbial species in tumormicroenvironment is indicative
of a contributory role in the development of CRC. Although
a causal role of intestinal microflora in CRC development has
not been demonstrated, evidence based on bacterial culture indi-
cated that some potential pro-oncogenic pathogens, which may
be the members of commensals, contribute to tumor initiation
and development.
In this study, we performed pyrosequencing based analysis
of 16S rRNA genes to analyze the overall structure of micro-
biota in patients with CRC and in healthy controls. We first
found that a significant difference in intestinal bacterial flora
was existed between the healthy individuals and CRC patients.
We further demonstrated that the composition of the tumor
microbiome differed from that of adjacent non-neoplastic tissue.
We also determined the subsite-specific alterations in the CRC
microbiota. The results of these studies provide evidence support-
ing that these bacteria could be used for microbiota-associated
diagnosis, prognosis prevention and treatment for CRC.
MATERIALS AND METHODS
ETHICS STATEMENT
All study protocols were reviewed and approved by the Ecthics
Committee of Shanghai Jiaotong University Affiliated Sixth
People’s Hospital and informed consent was provided by each
patient following the protocol approved by the Institutional
Review Board.
SAMPLE COLLECTION AND DNA EXTRACTION
Colorectal cancerous mucosa tissue samples were obtained intra-
operatively from recently diagnosed CRC patients [31 cancerous
tissues (T), 20 adjacent non-cancerous tissues (5 cm from the
cancerous tissue; P), 15 proximal colon cancer tissues (Tp), 16
distal colon cancer tissues (Td)]. Proximal colon cancers were
located in the ascending colon (5–10 cm from ileal valve); distal
colon cancers were located in the sigmoid colon (25–35 cm from
anus). Additionally, 30 corresponding colorectal mucosal sam-
ples of healthy volunteers [15 proximal colon tissues (Hp) and
15 distal colon tissues (Hd)] were collected during colonoscopy
(Table 1). All participants who met any of the exclusion cri-
teria as described were not enrolled in this study (Table 2),
including use of antibiotics within 2 months, and regular use of
Non-steroidal antiinflammatory drugs (NSAIDS), statins, or pro-
biotics. Individuals that complicated with actue/chronic intestinal
obstruction, chronic bowel disorders, and other foci of infec-
tions or food allergies/dietary restrictions were also excluded
from the study. Additional exclusion for CRC patients included
chemotherapy or radiation treatments prior to surgery. All par-
ticipants received conventional bowel preparation without pre-
operative antibiotics administration. Samples were transported
to the laboratory within 30min after collection by study par-
ticipants. DNA was extracted from all samples using MoBio
Powersoil DNA extraction kits (MoBio, Carlsbad, CA) according
Table 1 | Summary information of individuals in the study.
Group H T
Sample Tissue Tissue P-value
No. 30 31 >0.05
Male/female 14/16 15/16 >0.05
Age (year) 70±5.1 67±7.2 >0.05
BMI(kg/m2) 22.2±2.2 24.5±4.3 >0.05
Stage (A/B/C)† 8/15/8 >0.05
LOCATION
Proximal colon 15 14 >0.05
Distal colon 15 17 >0.05
Preoperative albumin (g/dL) 42.2±2.6 36.5±3.4 >0.05
Preoperative Hb (g/L) 126±12.4 123.2±19.6 >0.05
Creatinine (mg/dL) 1.1±0.2 1.2±0.13 >0.05
Abbreviations: BMI, body mass index,; No, number of participants.
† Dukes staging.
to the manufacturer’s instructions and stored at −20◦C prior to
amplification steps.
PYROSEQUENCING ANALYSIS
Amplification of the V3 region of the bacterial 16S rRNA gene
was performed in triplicate using primers 515F and 806R labeled
with 12-bp error correcting Golay barcodes (Kõljalg et al., 2013).
Twenty microliter reactions containing 5 Prime Hot Master Mix
(5 Prime, Inc., Gaithersburg, MD) were amplified at 94◦C for
5min followed by 35 cycles of 94◦C for 1min, 63◦C for 1min,
and 72◦C for 1min followed by a final extension at 72◦C for
10min. Replicate PCR reactions were combined and gel purified
using the GenElute Gel Extraction kit (Sigma-Aldrich, St. Louis,
MO), followed by an additional purification with AMpure beads
(Beckman Coulter, Indianapolis, IN) and quantified with the
PicoGreen DNA Assay (Invitrogen, Carlsbad, CA, USA) prior to
library pooling. Pyrosequencing was performed by the University
of South Carolina’s Engencore Sequencing Facility using a 454
Life Sciences GS FLX System with standard chemistry.
BIOINFORMATICS ANALYSIS
In order to gain high-quality and more precise bioinforma-
tion, we used effective sequences which contain some point
mutation and macromolecular homopolymers (Qiime, version
1.17 http://qiime.org/) (Hamady et al., 2008). The optimized
sequences were then clustered into opterational taxonomic
units (OTUs) using Usearch (version 7.1 http://qiime.org/)
with a criterion of a minimum similarity of 97%. Chimera
sequences arising from the PCR amplification were detected
and excluded from the OTUs using uchime (version 4.2.40
http://drive5.com/usearch/manual/uchime_algo.html) (Edgar,
2013). Representative OTUs were aligned to the optimized
sequences and the abundance of OTUs per samples was obtained
for performing the following further analysis.
Applying Bayesian algorithms of RDP classifier to analyse the
presentative OTUs at 97% similarity in the following databases:
16S bacteria and archaeal ribosomes Silva (Release115 http://
www.arb-silva.de) (Quast et al., 2013); RDP (Release 11.1 http://
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Table 2 | Inclusion and exclusion criteria of the individuals in the study.
CRC patients Healthy individuals
INCLUSION CRITERIA INCLUSION CRITERIA
Age 40–75 years Age 40–75 years
Diagnosis was confirmed by biopsy and histological analysis BMI 18.5–30 kg/m2
Undergone radical resection and no distant metastasis (including
liver)
EXCLUSION CRITERIA EXCLUSION CRITERIA
Age >75 years BMI >30 kg/m2
Pregnancy Pregnancy
Known lactose intolerance Known lactose intolerance
Clinically significant immunodeficiency Clinically significant immunodeficiency
Usage of antibiotics and additional gastrointestinal disorders (e.g.,
Crohn’s disease or ulcerative colitis)
Usage of antibiotics and additional gastrointestinal disorders (e.g.,
Crohn’s disease or ulcerative colitis)
Received antibiotics for the past 3 months before surgery Received antibiotics for the past 3 months before surgery
Evidence of infection Evidence of infection
Probiotics or prebiotics and excessive fiber intake within 2 weeks Probiotics or prebiotics and excessive fiber intake within 2 weeks
Undergoing emergency operation Undergoing emergency operation
Bowel preparation for colonoscopy within 6 days prior to surgery Bowel preparation for colonoscopy within 6 days prior to surgery
Undergoing proctectomy with low rectal anastomosis or surgery for
polypoid lesion
Undergoing proctectomy with low rectal anastomosis or surgery for
polypoid lesion
Laparoscopic surgery Laparoscopic surgery
Patients received preoperative chemotherapy or radiation therapy Suffered from other tumor
Abbreviations: BMI, body mass index; CRC, colorectal cancer.
rdp.cme.msu.edu/) (Cole et al., 2009); Greengene (Release 13.5
http://greengenes.secondgenome.com/) (DeSantis et al., 2006);
ITS fungus (Unite Release 5.0 http://unite.ut.ee/index.php); func-
tional genes FGR (Release7.3 http://fungene.cme.msu.edu/) (Fish
et al., 2013).
STATISTICAL ANALYSIS
All clinical statistical analyses were performed with the SPSS
18.0 software program for Windows (IBM). Pearson’s χ2-test and
Fisher’s exact test were applied to compare qualitative variables,
and quantitative variables were analyzed by Student’s t-test or
Spearman’s ρ rank correlation coefficient determination. A uni-
variate analysis was performed using the Kaplan–Meier method
(the log-rank test). A multivariate analysis was performed using a
Cox multivariate proportional hazard regression model in a step-
wise manner (backward, conditional). The model included all
clinicopathological variables found to have significant prognos-
tic value in the univariate analysis. A two-tailed value of P < 0.05
was considered to be statistically significant.
DATA ACCESS
The 16S sequence data generated in this study was submit-
ted to the GenBank Sequence Read Archive accession number
(SRP037786).
RESULTS
RICHNESS AND DIVERSITY ANALYSIS
A total of 1,378,458 high-quality and classifiable reads were
obtained from this study, with an average of 17,018 (n = 81) reads
per sample. At 3% dissimilarity level, a total of 148,959 OTUs in
all samples and an average of 1839 OTUs (n = 81) per sample
were identified. The value of Good’s coverage for each group was
over 93%, indicating that the 16S rRNA sequences identified in
the groups represent the majority of bacteria present in the study
samples. Whereas we didn’t observe the plateau of the refraction
curve (Figure S1) with the current sequencing. We examined the
estimators of community richness (Chao and Ace indexes) and
diversity and evenness (Shannon and Simpson indexes) in CRC
patient and healthy individual samples. While there were statis-
tically significant differences of Shannon and Simpson diversity
indexes between CRC and healthy individual [Shannon, 3.43 ±
0.60 vs. 4.01 ± 0.58 (95% CI of the difference, −0.89 to −0.28);
P < 0.001; Simpson, 0.24 ± 0.12 vs. 0.15 ± 0.12 (95% CI of
the difference, 0.04 to 0.16), P = 0.002], demonstrating the sig-
nificantly lower diversity found in CRC than healthy individual,
There were no statistically significant differences with Chao and
Ace index between the two groups [Chao, 3128 ± 646 vs. 2822 ±
627 (95% CI of the difference, −20.63 to 632.45), P = 0.06; Ace,
4900 ± 1129 vs. 4498 ± 1137 (95% CI of the difference, -88.51 to
1072.99), P = 0.09, Figure 1].
MUCOSA-ASSOCIATED MICROBIOTA IN CRC PATIENTS AND HEALTHY
INDIVIDUALS DIFFERED SIGNIFICANTLY
Bacterial communities from the mucosa of healthy individ-
uals and CRC patients were analyzed. The overall microbial
composition for each group at the phylum level is shown in
Figure 2A. According to the taxonomic results, we demonstrated
that Firmicutes, accounting for 63.46 and 43.36% [95% CI of the
difference, 5.67–34.32%] of the gut microbiota in CRC patients
and healthy individuals, respectively (P < 0.001), was the most
predominant phylum in CRC patients. While Proteobacteria
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FIGURE 1 | Alpha-diversity distances calculated using phylotype relative abundance measurements between healthy and CRC groups demonstrate
that the microbial richness of CRC patients is higher than healthy individuals, while the diversity has no statistical significance between two groups.
were the most predominant phylum in healthy individuals com-
pared to CRC patients with the proportion of 60.35 and 10.66%
[95% CI of the difference, −35.32 to −15.57%], respectively
(P < 0.001). And Bacteroidetes were the secondary phylum in
both groups with the proportion of 12.77 and 13.00% [95%
CI of the difference, −4.99 to 5.44%], respectively (P > 0.05).
Finally, Fusobacteria constituted the third most abundant phyla
in CRC group, contributing 10.58% compared with 0.03%
[95% CI of the difference, 0.25–12.68%] in healthy individuals
(P < 0.001).
At the genus level, our studies found the microbial com-
position differed significantly between CRC patients and
healthy individuals (Figure 2B). The genera Lactococcus
[50.85 vs. 25.35% (95% CI of the difference, 8.45–37.26%),
P = 0.007], Fusobacterium [10.08 vs. 0.01% (95% CI of the
difference, -0.27 to 10.63%), P = 0.032], Escherichia–Shigella
[2.92 vs. 0.22% (95% CI of the difference, 0.91–5.75%),
P = 0.004], Peptostreptococcusten [0.23 vs. 0.001% (95%
CI of the difference, -0.01 to 0.77%), P = 0.036] were
enriched in CRC patients, however, Epilithonimonas,
Flavobacterium (Flavobacteria), Pedobacter, Sphingobacterium
(Sphingobacteria), Caulobacter, Brevundimonas, Sphingomonas,
Sphingomonas (Alphaproteobacteria), Acidovorax,
Janthinobacterium (Betaproteo- bacteria), Buttiauxella, Rahnella,
Acinetobacter, Janthinobacterium, Psychrobacter, Pseudomonas,
Stenotrophomonas (Gammaproteobacteria), Psychrobacter,
Propioni- bacterium (Actinobacteria) were reduced in CRC
patients. Using Linear discriminant analysis (LDA) coupled with
effect size measurements (LEfSe), we found that Fusobacterium,
Prevotella and Peptostreptococcus were the key phylotypes that
contribute to the dysbiosis of mucosa-associated microbiota in
CRC patients, while Pseudomonas and Flavobacterium were the
key phylotypes that contribute to the distribution of mucosa-
adherent microbiota in healthy individuals (Figure 3).
BACTERIAL COMMUNITY IN CANCEROUS TISSUE AND ADJACENT
NON-CANCEROUS NORMAL TISSUE
According to hierarchical clustering analysis, the microbial com-
munities of cancerous tissues are more similar than are non-
cancerous tissues and can be distinguished from each other,
while the microbial communities of a tumor and matched non-
cancerous tissue from a given patient significantly differ from
each other (Figure 2E), This finding suggests that there are
marked differences in the microbial composition of tumor and
non-cancerous tissue.
A taxonomy-based comparison was performed to determine
the differences between the microbiota of cancerous tissues
and adjacent non-cancerous colorectal tissues. At the phylum
level, Firmicutes was the most predominant phylum, contribut-
ing 63.46 and 39.54% of the gut microbiota in cancerous tis-
sues and adjacent non-cancerous tissues, respectively, followed
by Bacteroidetes, which contributed 12.77 and 19.1%, respec-
tively. Proteobacteria, Fusobacteria, and Actinobacteria consti-
tuted the next most dominant phyla, contributing 10.66, 9.58,
and 1.46% of cancerous tissues, and 35.98, 0.57, and 3.48%
of adjacent non-cancerous tissues, respectively. Firmicutes was
statistically significantly more abundant in the gut micro-
biota of cancerous tissues than that of adjacent non-cancerous
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FIGURE 2 | Different structures of gut microbiota between healthy
individuals and CRC patients. (A) The dominant phyla of group
tumor and healthy. (B) The dominant genera of group tumor and
healthy. (C) The dominant phyla of group cancer and non-cancerous
mucosa. (D) The dominant genera of group cancer and cancerous
mucosa. (E) Hierarchical clustering of phylotype relative abundance
measurements demonstrates that microbial composition of tumor
samples from different individuals is more highly correlated than
tumor/health samples within individuals. (F) Hierarchical clustering of
proximal and distal CRC.
FIGURE 3 | Histogram of the LDA scores for differentially abundant genera. Cladogram was calculated by LEfSe, a metagenome analysis approach.
tissues (P = 0.03), and Proteobacteria was statistically signifi-
cantly less abundant in the gut microbiota of cancerous tis-
sues than that of adjacent non-cancerous tissues (P < 0.01). No
statistically significant differences of Fusobacteria were observed
in the cancerous tissues compared with non-cancerous tissues
(Figure 2C).
At the genus level, our studies also demonstrated that
the microbial composition was significantly different and
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a greater number of genera were present in cancerous tis-
sues compared to adjacent non-cancerous tissues. Genera
Lactococcus, Bacteroides, Fusobacterium, Prevotella, and
Streptococcus exhibited more enriched in cancerous tissues
than adjacent non-cancerous tissues. However, Pseudomonas
were statistically significantly enriched in adjacent non-
cancerous tissues compared to cancerous tissues (P < 0.001,
Figure 2D).
COMPARISON OF GUT MICROBIOTA BETWEEN PROXIMAL COLON
CANCER AND DISTAL COLORECTAL CANCER
The microbial composition evaluated in this study resulted as
being different from proximal to distal tumors (Figure 2F).
Principal component analysis (PCA) based on the relative abun-
dance of genera revealed that a significant separation in bac-
terial community composition between proximal and distal
tumors using the first two principal component scores of PC1
and PC2 (39.07 and 11.2% of explained variance, respectively;
Figure 4). We found that the dominant phyla were Firmicutes,
Bacteroidetes, and Proteobacteria. They acccounted for above
98% of all phylums.
At genus level, bacterial genera were analyzed that were pre-
sented at a relative abundance >0.1%, which accounted for
over 97% of total microbiota. Four hundred and sixty-eight
bacterial phylotypes were identified from this study. Among of
which, 279 (59.6%) presented in proximal colon, 335 (71.6%)
in distal colon, which is concordant with the result of diver-
sity index analyses of the gut flora, indicating an increasing
microbial richness from proximal colon to rectal cancer. In prox-
imal tumors, Prevotella, Pyramido- bacterium, Selenomonas, and
Peptostreptoccus exhibited a relatively higher abundance. While in
distal colorectal tumors, Fusobacterium, Escherichia-Shigella, and
Leptotrichia were relatively abundant compared with proximal
cancerous tissue.
FIGURE 4 | Principal component analysis (PCA) scores plot based on
the relative abundance of OTUs (97% similarity level). Each symbol
represents a sample. Green circles represent proximal CRC. Red quadrates
represent distal CRC.
DISCUSSION
In summary, in this study, we first compared the mucosa-
associated microbiota composition between healthy individuals
and CRC patients using the platform of Roche 454 sequencer.
We also analyzed the mucosa-associated microbial composi-
tion in cancerous tissue and the adjacent non-neoplastic tis-
sue. We revealed significant difference of gut microbiota in
CRC patients compared with healthy individuals. The rela-
tive abundance of dominant phyla Firmicutes, Proteobacteria,
Fusobacteria, and dominant genera Lactococcus, Fusobacterium,
Escherichia-Shigella, Peptostrepto- coccus were all different. A sig-
nificantly higher abundance of Firmicutes and Fusobacteria in
cancerous tissues were found than that in healthy individuals,
while Proteobacteria was less abundant in CRC group. Firmicutes,
which as part of the gut microbiome has been shown to be
involved in energy resorption (Costello et al., 2010), is highly
diverse in phenotypic characteristics. Members of the phylum dis-
play a disparate distribution in which some species are enriched
in the tumor tissue whereas others inhabit healthy gut. For
instance, Moore found Eubacterium rectale, Eubacterium eligens
of Firmicutes have a significant correlation with CRC (Moore
and Holdeman Moore, 1986). In contrast, Proteobacteria, which
was less abundant in CRC patients, are generally regarded as gut
commensals with potential-pathogenic features (Joly et al., 2010).
Our finding indicated that bacteria belonging to the same taxo-
nomic clade can play distinct functional roles in gut environment
depending on their functional repertoire, including toxins, viru-
lence factors, and other factors that promote interactions between
the bacteria and their microenvironment.
The most prominent and consistent findings is the enrichment
of Fusobacterium within the tumor microenvironment. It has
been reported that Fusobacterium may be associated with inflam-
matory bowel diseases (IBD), including both ulcerative colitis and
Crohn’s disease (Neut et al., 2002; Ohkusa et al., 2002; Strauss
et al., 2011), these two diseases are known risk factors for colorec-
tal cancer. In further study, Fusobacterium species can promote
host proinflammatory response (Moore and Moore, 1994) and
possess virulence characteristics that promote their adhesiveness
to host epithelial cells (Bachrach et al., 2005; Uitto et al., 2005)
and their ability to invade into epithelial cells (Castellarin et al.,
2011). Tomomitsu found Fusobacterium enrichment is associated
with specific molecular subsets of CRCs including CIMP posi-
tivity, TP53 wild type, hMLH1 methylation positivity, MSI and
CHD7/8 mutation positivity (Tahara et al., 2014). Lactococcus,
which are generally regarded as gut commensals with probiotic
features, were over-represented in CRC patients, suggesting the
microbial shifts are caused by the quite dramatic physiological
and metabolic alterations that result from colon carcinogene-
sis itself (Sansonetti, 2004; Hirayama et al., 2009). According
to driver–passenger model for colorectal cancer (Tjalsma et al.,
2012), these species may be regarded as CRC bacterial passen-
gers. As expected, our findings indicated that the structure of
mucosa-associated microbiota in cancerous tissue differs sig-
nificantly from that of the adjacent non-neoplastic tissue. The
microbial communities of cancerous tissues were more similar
to each other than that of tumor and matched non-cancerous
colon from a given patient tumors. Proximal colon cancer tissues
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microbial structures also exhibited similarity with that of distal
colon cancer, this is partially due to the unavoidable continuity
that the feces pass through gut. Hierarchical clustering analysis
of the species-specific relative abundances of microbial sequences
confirmed this result.
Harold and his colleagues have proposed a driver–passenger
model for colorectal cancer, that is, CRC can be initiated by
“driver” bacteria, which are eventually replaced by “passenger”
bacteria that either promote or stall tumorigenesis. The bac-
terial drivers and passengers have distinct temporal roles in
CRC pathogenesis. We hypothesized that there are also cer-
tain bacteria that are directly pro-oncogenic and capable of
remodeling the mucosal immune response and colonic bacterial
community to further promote CRC. For example, Pseudomonas,
which belongs to genus of Gram-negative, aerobic gammapro-
teobacteria, increasingly recognized as an emerging oppor-
tunistic pathogen of clinical relevance (Decker and Palmore,
2014), is significantly less abundant in cancerous tissue com-
pared to normal tissue. This finding was confirmed in mucosa-
adherent microbiota of CRC patients compared to adjacent
non-cancerous tissues and healthy controls. Other remarkable
observation concerned the decreased presence of members of
Escherichia, Citrobacter, Shigella, Flavobacterium, Acinetobacter,
Chryseobacterium in tumor tissue of the investigated CRC
patients. Shigella, which were recognized as aetiological agents of
human diarrheal disease by a CRC-drivingmechanism to prolong
inflammatory response, could increase an individual’s suscepti-
bility to CRC (Paul et al., 2006; DuPont, 2009; Maggio et al., 2009;
Housseau and Sears, 2010). Moreover, it was recently found that
Shigella were over-represented in the mucosa-associated micro-
biome of patients with an adenoma (Maggio et al., 2009; Shen
et al., 2010). In addition, certain Escherichia coli strains, which
harbor the polyketide synthetase (pks) island encoding genotoxin,
can induce single-strand DNA breaks (Nougayrède et al., 2006),
Subsequent activating DNA damage- induced signaling pathways
and increase the mutation rate of infected cells. Therefore, these
species may be associated with the early stages of CRC, including
adenomas, and then disappear from cancerous tissue as the dis-
ease progresses. This data suggest that these potential pathogens
are part of the intrinsic bacterial drivers of CRC patients, but
outcompeted by commensal bacteria during disease progression.
This observation is consistent with our hypothesis.
However, the dramatic physiological and metabolic alter-
ations that occur during colon carcinogenesis may disrupt the
structure of indigenous bacterial communities. Some species
rarely colonizing colon will be adapted to the new environ-
ment. For example, Fusobacterium is a genus of obligate anaer-
obic, Gram-negative bacteria that usually colonize in the oral
cavity of nearly all humans, some strains of Fusobacterium con-
tribute to the development of dental plaques and periodontal
disease (Allen et al., 2011; He et al., 2011). These bacteria are
poor colonizers of healthy colon mucosa and cannot breach
the intact colon wall. However, when an inflammation, ade-
noma or carcinoma develops, the deterioratedmicroenvironment
of the colon wall may allow these microorganisms including
Fusobacterium, Peptostreptococcus, and Lactococcus to access and
adhere the basement membrane. We speculated one of reasons
may be the formation of local anaerobic microenvironment
induced by aerobic bacteria such as pseudomonas, which is suit-
able for these potential pathogens to colonize. Different from
Fusobacterium, however, Lactococcus, which produce a single
product-lactic acid, plays a probiotic role in colon. It is not yet
clear whether these bacterial passengers merely benefit from the
CRCmicroenvironment or they also play an active part in disease
progression.
Additionally, our study also demonstrates several signif-
icant differences between proximal and distal CRC in the
mucosal microbial composition. The relative abundance of
dominant genus Lactococcus, Fusobacterium, Pseudomonas, and
Flavobacterium are similar between proximal and distal colon.
Interestingly, a common characteristic of these bacteria is they all
are “passenger bacteria” as discussed in the previous section. One
interpretation of this observation may be that the similar tumor
microenvironment develop during colon carcinogenesis, includ-
ing pH, temperature and oxygen. In contrast, Escherichia-Shigella,
which may belong to potential pathogen of CRC, is highly
enriched in proximal colon. The highly enriched Gram-negative
bacteria Bacteroides in distal colon may impart both beneficial
and detrimental effects on host physiology through their colito-
genic or probiotic potential (Zhu et al., 2014). One of human
colonic commensal, enterotoxigenic B. Fragilis (ETBF) have been
demonstrated to produce a metalloprotease (also known as frag-
ilysin) in colon cancer patients (Toprak et al., 2006; Wu et al.,
2006). This pathogen can facilitate tumorigenesis by triggering
augmented expression of inter leukin-17 (IL-17) by T helper 17
(TH17) cells in the lamina propria in a mouse model of ETBF-
induced colitis and carcinogenesis (Wu et al., 2009). In addition,
Prevotella, which have been reported in the oral and gastric cav-
ities (Dicksved et al., 2009), was highly enriched in proximal
colon cancer that appeared to be linked with elevated IL17 pro-
ducing cells in the mucosa of CRC patients (Sobhani et al.,
2011).
In summary, our study suggest that gut dysbiosis are associ-
ated with CRC risk largely through metabolic exchange or direct
interaction with the host. We speculate two kinds of function-
ally different bacteria present within tumor microenvironment
during the process of tumorigenesis. One is certain potential
pro-oncogenic pathogens such as ETBF and Escherichia-Shigella,
which can promote tumorigenesis as driver bacteria. While an
altered tumor microenvironment develops with the disease pro-
gression, the other kind of bacteria, which may play either tumor-
promoting or tumor-suppressing role, can be more adapted of
the new environment than driver bacteria and survive finally. Our
findings also reveal species-specific alterations between proximal
and distal colon cancer. Still, further studies on wide sample sizes
will be needed to identify the role of the different microbiota.
Therefore, our results will be useful to promote the develop-
ment of novel bacteria-related diagnostic tools and therapeutic
interventions.
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